Bms Performance company information, Employees & Contact Information

Pharmaceutical research and development pipeline Bristol Myers Squibb

In UK, Big Pharma pressure campaign rolls on as Bristol Myers plans US-level pricing for Cobenfy Fierce Pharma

Bristol Myers plans UK launch of schizophrenia drug Cobenfy, matching US price Reuters

Worldwide locations Bristol Myers Squibb

BMS says schizophrenia drug Cobenfy will cost same in UK as in US FirstWord Pharma

AbbVie joins BMS in taking a hard line on UK drug pricing pharmaphorum

UK under pressure as BMS sets US-level price for schizophrenia drug Financial Times

BMS Adds To Big Pharma Pressure On UK With US Pricing For Cobenfy Citeline News & Insights

BMS to Launch Cobenfy in UK at Similar List Price to U.S. NAVLIN DAILY

Business Moves: Howden Japan Acquires Holos; Ageas Buys Saga's Underwriting Biz; BMS Purchases Australian Property Broker; UK's Direct Line Now Owned by Aviva Insurance Journal

BMS says it will set Cobenfy's UK price the same as the US pharmaphorum

2024 Ends With Greenlights for Merck’s PAH Drug in UK and BMS’ Opdivo Injection in US BioSpace

BMS Group buys Istanbul-based insurance broker Oria Sigorta Insurance Business America

UK Biobank consortiums unveil groundbreaking study furthering revolutionary insights into human health and disease Bristol Myers Squibb

Clinical trials & studies Bristol Myers Squibb

Bristol Myers Squibb earns coveted spot on this year's UK’s Best Workplaces in BioPharma list Bristol Myers Squibb

Pre-approval access to investigational medicines Bristol Myers Squibb

Guy Oliver appointed as General Manager for Bristol Myers Squibb UK and Ireland Bristol Myers Squibb

Squaring the impossible circle: Looking to a future of improved cancer patient experience and efficient care Bristol Myers Squibb

Lung cancer experts address unwarranted variation in diagnosis and treatment Bristol Myers Squibb

Putting Moreton on the map: How our R&D site in the North-West of England is harnessing local investment to become a global hub for innovation Bristol Myers Squibb

Celebrating 10 years of C2C4C Bristol Myers Squibb

Achieving sustainability goals through innovation Bristol Myers Squibb

Bristol Myers Squibb expands health equity grant initiatives to improve health outcomes Bristol Myers Squibb

Cancer Equals: UK wide research highlights differences in cancer care Bristol Myers Squibb

BMS UK CEO Ian Gormley on becoming part of the DE&I solution Insurance Business America

BMS expands energy team with three senior appointments Insurance Business America

Driving a transformative approach to understanding menopause in the workplace Bristol Myers Squibb

BMS sees CAR-T sales rocket in line with increased capacity BioProcess International

BMS says subcutaneous version of Opdivo gets EU nod FirstWord Pharma

BMS group taps UK chief growth officer Insurance Business America

BMS bags advanced melanoma win for Opdualag in the UK Pharmaceutical Technology

Lilly, AbbVie, BMS and more rally against UK's 'arbitrary' growth cap on branded drug market Fierce Pharma

BMS receives NICE recommendation for immunotherapy combination in colorectal cancer PMLiVE

Layoff Tracker: Alector Nearly Halves Workforce Following Dementia Drug Phase III Failure BioSpace

White & Case advises Eurazeo on investment in BMS White & Case LLP

People Moves: BMS Launches Global Healthcare Liability Unit, Led by Wendin From Carpenter; Gallagher Re Taps Hiscox's Marling as UK COO Insurance Journal

Bristol's Opdivo wins NICE backing in certain bladder cancer patients, but with caveats Fierce Pharma

BMS and Shine Cancer Support’s UK research reveals disparities in cancer diagnosis PMLiVE

BMS promotes Watkins to UK chief growth officer Global Reinsurance

BMS Group expands early careers apprenticeship program in London Insurance Business America

BMS hires operating chief from Gallagher Re Business Insurance

MHRA approval for BMS’ SC Opdivo The Pharma Letter

BMS introduces new group CFO and executive director Insurance Business America

Big pharma is at war with the UK, and the government can’t back down now | Nick Dearden The Guardian

BMS to acquire UK insurance broker David Roberts & Partners Life Insurance International

BMS Group faces possible sale – report Insurance Business America

Insurance hires: Mosaic, Carbon, BMS, Coalition Insurance Business America

BMS names president of specialty reinsurance arm Insurance Business America

BMS expands Iberian business with Eisenar acquisition Insurance Business America

BMS buying DR&P stake from Inflexion Insurance Business America

BMS Re announces key appointments in UK, US Insurance Business America

BMS Group names chief operating officer Insurance Business America

BMS Group secures new investor Insurance Business America

BMS appoints CEO of UK business Bermuda Re

BMS boosts its capital advisory team Bermuda Re

Discount Retailer B&M's Annual Sales Disappoint On Soft UK Demand ESM Magazine

U.K.-based Broker BMS Group Opens New York Office Insurance Journal

BMS kicks off UK regional build-out with £450mn+ DR&P deal Insurance Insider

BMS appoints new head for UK and Ireland PMLiVE

BMS appoints Ian Gormley UK CEO Royal Gazette | Bermuda

BMS launches hepatitis C pill Daklinza in the UK PMLiVE

BMS Group Limited appoints marine division managing director Insurance Business America